Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
Clinical trial NCT01303965 · TERMINATED
Trial details
- NCT number
- NCT01303965
- Sponsor
- Sherif S. Farag
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-07
- Primary completion
- 2014-09-23
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.